Jeanne Thoma

This profile gathers the share dealings of Jeanne Thoma across 2 companies, led by ANI Pharmaceuticals Inc and Avid Bioservices, Inc. Between 3 December 2021 and 11 September 2026, the trades on record add up to 15 filings.

The open-market side counts 1 purchase for €44k alongside 2 sales for €590k. Netting one side against the other leaves €545k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 6 option exercises. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 14 September 2026: an open-market sale of €62k, in ANI Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,761 days ago, on 22 December 2021. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.